Skip To Main Content

Artikelen

Sort by

Filters

Resetten
  • Therapeutische gebieden

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

Guidelines

cGVHD criteria

Effect of cGVHD

Overview of cGvHD

Actors

Immunology mechanism

Evolving Basal Insulin Therapy: From First-Generation to Second-Generation Analogues in Diabetes Care

Patient-Reported Outcome Measures (PROMs) in Dermatology

Interview by DermTalks
DermTalks is a project led with a board of dermatologists and intended to address current challenges, data gaps and emerging trends in dermatology across North-European countries.

Speaker: Prof. Mette Deleuran, Associate Professor and Chair of the Department of Dermatology and Venereology, Aarhus University Hospital, Denmark.

Are you ready to test your knowledge about renal involvement in Fabry?

Autoimmune Type 1 Diabetes

The Type 1 Diabetes (T1D) field is evolving.

Recognition of the presymptomatic stages in T1D is growing.1-4 

The clinical benefits of early detection of T1D are being highlighted.3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.1,2

A Paradigm Shift in Early Detection of Autoimmune Type 1 Diabetes

Autoimmune Type 1 diabetes (T1D) is undergoing a fundamental transformation in how the medical community approaches diagnosis and care.